(Q39523376)

12 September 2017

title

Effect of a half dose of tamoxifen on proliferative activity in normal breast tissue (English)

1 reference

12 September 2017

1 reference

J R Bernardes

1

1 reference

12 September 2017

S Nonogaki

2

1 reference

12 September 2017

M T Seixas

3

1 reference

12 September 2017

G Rodrigues de Lima

4

1 reference

12 September 2017

E C Baracat

5

1 reference

12 September 2017

L H Gebrim

6

1 reference

12 September 2017

publication date

1 October 1999

1 reference

International Journal of Gynecology and Obstetrics

12 September 2017

published in

1 reference

12 September 2017

volume

67

1 reference

12 September 2017

issue

1

1 reference

12 September 2017

page(s)

33-38

1 reference

Potential role of tamoxifen in prevention of breast cancer

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2899%2900092-2

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2899%2900092-2

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2899%2900092-2

Estrogenic activity of tamoxifen on normal mammary parenchyma in the luteal phase of the menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2899%2900092-2

Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2899%2900092-2

Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2899%2900092-2

Use of tamoxifen for breast cancer: twenty-eight years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2899%2900092-2

Dosage and duration of tamoxifen treatment for mastalgia: a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2899%2900092-2

Influence of the antioestrogen tamoxifen on normal breast tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2899%2900092-2

Endocrine Consequences of Continuous Antiestrogen Therapy with Tamoxifen in Premenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2899%2900092-2

Sex hormones in postmenopausal women with breast cancer on tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2899%2900092-2

Effects of tamoxifen on the breast in the luteal phase of the menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2899%2900092-2

Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2899%2900092-2

Effect of the anti-oestrogen tamoxifen on plasma levels of luteinizing hormone, follicle-stimulating hormone, prolactin, oestradiol and progesterone in normal pre-menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2899%2900092-2

A comparsion of the effects of clomiphene and tamoxifen treatment on the concentrations of oestradiol and progesterone in the peripheral plasma of infertile women

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2899%2900092-2

Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0020-7292%2899%2900092-2

10.1016/S0020-7292(99)00092-2

7 January 2021

Identifiers

DOI

1 reference

12 September 2017

1 reference